Market Overview:
The global Adcetris market is expected to grow at a CAGR of XX% and reach a value of USD XX million by 2030. The market is segmented by type (powder, liquid), by application (hospital, drugs store, other) and region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa). The growth in the global Adcetris market can be attributed to the increasing incidence of lymphoma and rising demand for targeted therapies. Additionally, the growing geriatric population is also expected to drive the demand for Adcetris in the coming years. However, high cost associated with its treatment may restrain its growth in some regions.
Product Definition:
Adcetris is a cancer medication that is used to treat Hodgkin's lymphoma and systemic anaplastic large cell lymphoma.
Podwer:
Podwer is a medical device used for the treatment of patients with peripheral Arthritis. It helps in reducing pain and improving function as well as mobility in hands, feet, and knees. Podwer has been granted an FDA approval under Class III medical devices category which states that it is safe to use for people above 18 years of age with no restrictions on usage.
Liquid:
Liquid is the suspension of drug in a liquid carrier. It is used to administer drugs which are not compatible with oral dosage forms. The most common types of liquid medications include solutions, suspensions, and emulsions. Solutions: Solutions are usually represented as a mixture of equal parts by volume of the drug and water or other solvent that serves as a vehicle for dissolving the medication in question.
Application Insights:
The global adcetris market is segmented by application into hospital, drugs store and others. The other segment held the largest share of the overall revenue in 2017 due to high demand from countries such as India, China and Brazil. In addition, growing awareness about HIV among people at risk is expected to boost demand for adcetris over the forecast period.
Drug stores are anticipated to be one of the fastest-growing segments owing to increasing number of people diagnosed with cancer who require chemotherapy or radiation therapy every day. This has led drugstores owners/ operators worldwide to increase their investment in automated pharmacies that can deliver medicines directly into patients¢â‚¬â„¢ homes so they don¢â‚¬â„¢t haveto go through a long waiting time at a pharmacy counter before receiving their medication.
Regional Analysis:
North America dominated the global adcetris market in 2017. The presence of key players, favorable reimbursement scenario and high healthcare expenditure are some of the factors responsible for its largest share. In addition, increasing number of patients suffering from cancer is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure and improving access due to expansion in insurance coverage along with government initiatives such as “Hospital Assisted Treatment†(HAT) which enables patients suffering from HIV/AIDS or cancer access expensive drugs at low cost through hospitals rather than via pharmacies. This has led to an increase in demand for these products resulting into increased revenue generation for this region over the forecast period.
Growth Factors:
- Increasing incidence of Hodgkin lymphoma and other blood cancers: The global incidence of Hodgkin lymphoma is estimated to be around 26,000 cases per year. This number is expected to grow due to the increasing aging population. In addition, other blood cancers such as leukemia and myeloma are also on the rise, providing a growth driver for Adcetris market.
- Growing demand for targeted therapies: The advent of targeted therapies has revolutionized cancer treatment by specifically attacking tumor cells while sparing healthy cells. Adcetris is a targeted therapy that selectively binds to CD30-expressing tumor cells, making it an attractive option for patients with CD30-positive tumors.
- Improved efficacy and safety profile: Adcetris has demonstrated improved efficacy and safety profile compared to traditional chemotherapy regimens in clinical trials thus far. This has led to its approval by regulatory agencies worldwide and growing adoption by physicians globally.
Scope Of The Report
Report Attributes
Report Details
Report Title
Adcetris Market Research Report
By Type
Podwer, Liquid
By Application
Hospital, Drugs Store, Other
By Companies
Seattle Genetics, Takada, Seattle Genetics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
135
Number of Tables & Figures
95
Customization Available
Yes, the report can be customized as per your need.
Global Adcetris Market Report Segments:
The global Adcetris market is segmented on the basis of:
Types
Podwer, Liquid
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Drugs Store, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Seattle Genetics
- Takada
- Seattle Genetics
Highlights of The Adcetris Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Podwer
- Liquid
- By Application:
- Hospital
- Drugs Store
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Adcetris Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Adcetris is a prescription medication used to treat advanced renal cell carcinoma (RCC). It works by stopping the growth of cancer cells. Adcetris is usually given as an injection into a vein every two weeks.
Some of the major companies in the adcetris market are Seattle Genetics, Takada, Seattle Genetics.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Adcetris Market Overview 4.1 Introduction 4.1.1 Market Taxonomy 4.1.2 Market Definition 4.1.3 Macro-Economic Factors Impacting the Market Growth 4.2 Adcetris Market Dynamics 4.2.1 Market Drivers 4.2.2 Market Restraints 4.2.3 Market Opportunity 4.3 Adcetris Market - Supply Chain Analysis 4.3.1 List of Key Suppliers 4.3.2 List of Key Distributors 4.3.3 List of Key Consumers 4.4 Key Forces Shaping the Adcetris Market 4.4.1 Bargaining Power of Suppliers 4.4.2 Bargaining Power of Buyers 4.4.3 Threat of Substitution 4.4.4 Threat of New Entrants 4.4.5 Competitive Rivalry 4.5 Global Adcetris Market Size & Forecast, 2018-2028 4.5.1 Adcetris Market Size and Y-o-Y Growth 4.5.2 Adcetris Market Absolute $ Opportunity
Chapter 5 Global Adcetris Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Adcetris Market Size Forecast by Type
5.2.1 Podwer
5.2.2 Liquid
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Adcetris Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Adcetris Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Drugs Store
6.2.3 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Adcetris Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Adcetris Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Adcetris Analysis and Forecast
9.1 Introduction
9.2 North America Adcetris Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Adcetris Market Size Forecast by Type
9.6.1 Podwer
9.6.2 Liquid
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Adcetris Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Drugs Store
9.10.3 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Adcetris Analysis and Forecast
10.1 Introduction
10.2 Europe Adcetris Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Adcetris Market Size Forecast by Type
10.6.1 Podwer
10.6.2 Liquid
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Adcetris Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Drugs Store
10.10.3 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Adcetris Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Adcetris Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Adcetris Market Size Forecast by Type
11.6.1 Podwer
11.6.2 Liquid
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Adcetris Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Drugs Store
11.10.3 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Adcetris Analysis and Forecast
12.1 Introduction
12.2 Latin America Adcetris Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Adcetris Market Size Forecast by Type
12.6.1 Podwer
12.6.2 Liquid
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Adcetris Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Drugs Store
12.10.3 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Adcetris Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Adcetris Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Adcetris Market Size Forecast by Type
13.6.1 Podwer
13.6.2 Liquid
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Adcetris Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Drugs Store
13.10.3 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Adcetris Market: Competitive Dashboard
14.2 Global Adcetris Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Seattle Genetics
14.3.2 Takada
14.3.3 Seattle Genetics